MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jac/dku014

Медицинская библиотека · The Journal of antimicrobial chemotherapy · 2014

Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial.

Hamasuna Ryoichi, Tanaka Kazushi, Hayami Hiroshi, Yasuda Mitsuru, Takahashi Satoshi, Kobayashi Kanao, Kiyota Hiroshi, Yamamoto Shingo, Arakawa Soichi, Matsumoto Tetsuro, Japanese Research Group for UTI (JRGU)

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

The increasing prevalence of resistant bacteria such as fluoroquinolone-resistant or extended-spectrum β-lactamase-producing strains in pathogens causing acute uncomplicated cystitis has been of concern in Japan. Faropenem sodium is a penem antimicrobial that demonstrates a wide antimicrobial spectrum against both aerobic and anaerobic bacteria. It is stable against a number of β-lactamases.

METHODS

We compared 3 and 7 day administration regimens of faropenem in a multicentre, randomized, open-label, controlled study.

RESULTS

In total, 200 female patients with cystitis were enrolled and randomized into 3 day (N = 97) or 7 day (N = 103) treatment groups. At the first visit, 161 bacterial strains were isolated from 154 participants, and Escherichia coli accounted for 73.9% (119/161) of bacterial strains. At 5-9 days after the completion of treatment, 73 and 81 patients from the 3 day and 7 day groups, respectively, were evaluated by intention-to-treat analysis; the microbiological efficacies were 58.9% eradication (43/73), 20.5% persistence (15/73) and 8.2% replaced (6/73), and 66.7% eradication (54/81), 6.2% persistence (5/81) and 7.4% replaced (6/81), respectively (P = 0.048). The clinical efficacies were 76.7% (56/73) and 80.2% (65/81), respectively (P = 0.695). Adverse events due to faropenem were reported in 9.5% of participants (19/200), and the most common adverse event was diarrhoea.

CONCLUSIONS

The 7 day regimen showed a superior rate of microbiological response. E. coli strains were in general susceptible to faropenem, including fluoroquinolone- and cephalosporin-resistant strains.

Для цитирования: Hamasuna Ryoichi, Tanaka Kazushi, Hayami Hiroshi, Yasuda Mitsuru, Takahashi Satoshi, Kobayashi Kanao, Kiyota Hiroshi, Yamamoto Shingo, Arakawa Soichi, Matsumoto Tetsuro, Japanese Research Group for UTI (JRGU). Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial.. The Journal of antimicrobial chemotherapy. 2014. DOI: 10.1093/jac/dku014.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.